Aberrant L-Fucose accumulation and increased core fucosylation are metabolic liabilities in mesenchymal glioblastoma. Pieri V, Gallotti AL, Drago D, Cominelli M, et al. Cancer Res 2022 Nov 21:CAN-22-0677. doi: 10.1158/0008-5472.CAN-22-0677.

Read + Share

Amedeo Smart

Independent Medical Education

Pieri V, Gallotti AL, Drago D, Cominelli M, et al. Aberrant L-Fucose accumulation and increased core fucosylation are metabolic liabilities in mesenchymal glioblastoma. Cancer Res 2022 Nov 21:CAN-22-0677. doi: 10.1158/0008-5472.CAN-22-0677.
PMID: 36409826